Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.
One of the greatest obstacles to the control of malaria has been the spread of resistance to drugs used on a large scale. This review provides an update of the current understanding of the molecular basis for antimalarial drug resistance. Parasite intrinsic resistance is just one component that determines the in vivo efficacy of a drug. Human immune responses and pharmacologic properties play important roles in determining the clinical outcome of treatment. The emergence and spread of resistance also results from an interplay of these factors. Current efforts to characterize and deter resistance to new combination therapy are also discussed.
Travassos
Mark A
MA
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Laufer
Miriam K
MK
D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use; D004351:Drug Resistance; D054884:Host-Pathogen Interactions; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy; D010963:Plasmodium falciparum / Q000187:drug effects*
D000962:Antimalarials